126 related articles for article (PubMed ID: 28566557)
1. The prognostic significance of ING4 expression on gastric gastrointestinal stromal tumors by immunohistochemistry.
Sahin S; Ekinci O; Seckin S; Dursun A
Ann Ital Chir; 2017; 88():311-317. PubMed ID: 28566557
[TBL] [Abstract][Full Text] [Related]
2. Low ING4 protein expression detected by paraffin-section immunohistochemistry is associated with poor prognosis in untreated patients with gastrointestinal stromal tumors.
Nanding A; Tang L; Cai L; Chen H; Geng J; Liu X; Ning X; Li X; Zhang Q
Gastric Cancer; 2014 Jan; 17(1):87-96. PubMed ID: 23504291
[TBL] [Abstract][Full Text] [Related]
3. Thymosin beta-4 overexpression correlates with high-risk groups in gastric gastrointestinal stromal tumors: A retrospective analysis by immunohistochemistry.
Şahin S; Ekinci O; Seçkin S; Dursun A
Pathol Res Pract; 2017 Sep; 213(9):1139-1143. PubMed ID: 28756979
[TBL] [Abstract][Full Text] [Related]
4. Role of Ki-67 as a prognostic factor in gastrointestinal stromal tumors.
Belev B; Brčić I; Prejac J; Golubić ZA; Vrbanec D; Božikov J; Alerić I; Boban M; Razumović JJ
World J Gastroenterol; 2013 Jan; 19(4):523-7. PubMed ID: 23382631
[TBL] [Abstract][Full Text] [Related]
5. The Diagnostic and Prognostic Utility of DOG1 Expression on Gastrointestinal Stromal Tumors.
Şahin S; Ekinci Ö; Seçkin S; Dursun A
Turk Patoloji Derg; 2017; 33(1):1-8. PubMed ID: 28044310
[TBL] [Abstract][Full Text] [Related]
6. Clinical and prognostic significance of Raf kinase inhibitory protein expression in gastrointestinal stromal tumors.
Wang Y; Chen JJ; Wang XF; Wang Q
World J Gastroenterol; 2018 Jun; 24(23):2508-2517. PubMed ID: 29930472
[TBL] [Abstract][Full Text] [Related]
7. Expression level of the mitotic checkpoint protein and G2-M cell cycle regulators and prognosis in gastrointestinal stromal tumors in the stomach.
Fujita A; Yamamoto H; Imamura M; Nakamura N; Maehara Y; Tsuneyoshi M; Oda Y
Virchows Arch; 2012 Feb; 460(2):163-9. PubMed ID: 22190007
[TBL] [Abstract][Full Text] [Related]
8. GIST Manifesting as a Retroperitoneal Tumor: Clinicopathologic Immunohistochemical, and Molecular Genetic Study of 112 Cases.
Miettinen M; Felisiak-Golabek A; Wang Z; Inaguma S; Lasota J
Am J Surg Pathol; 2017 May; 41(5):577-585. PubMed ID: 28288036
[TBL] [Abstract][Full Text] [Related]
9. Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age.
Miettinen M; Wang ZF; Sarlomo-Rikala M; Osuch C; Rutkowski P; Lasota J
Am J Surg Pathol; 2011 Nov; 35(11):1712-21. PubMed ID: 21997692
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of carbonic anhydrase II and Ki-67 proteins in prognosis of gastrointestinal stromal tumors.
Liu LC; Xu WT; Wu X; Zhao P; Lv YL; Chen L
World J Gastroenterol; 2013 Apr; 19(16):2473-80. PubMed ID: 23674848
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of gastrointestinal bleeding and expression of PTEN and Ki-67 on primary gastrointestinal stromal tumors.
Wang H; Chen P; Liu XX; Zhao W; Shi L; Gu XW; Zhu CR; Zhu HH; Zong L
World J Surg Oncol; 2014 Apr; 12():89. PubMed ID: 24712384
[TBL] [Abstract][Full Text] [Related]
12. Differential cellular localization of CELSR2 and ING4 and correlations with hormone receptor status in breast cancer.
Jiang L; Zhang X; Xiang C; Geradts J; Wei Q; Liang Y; Huang H; Xu JF
Histol Histopathol; 2018 Aug; 33(8):835-842. PubMed ID: 29489009
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological characteristics and prognosis of primary appendiceal stromal tumors.
Zhang B; Zheng GL; Zhu HT; Zhao Y; Zheng ZC
World J Surg Oncol; 2018 Nov; 16(1):225. PubMed ID: 30445975
[TBL] [Abstract][Full Text] [Related]
14. Reduced expression and novel splice variants of ING4 in human gastric adenocarcinoma.
Li M; Jin Y; Sun WJ; Yu Y; Bai J; Tong DD; Qi JP; Du JR; Geng JS; Huang Q; Huang XY; Huang Y; Han FF; Meng XN; Rosales JL; Lee KY; Fu SB
J Pathol; 2009 Sep; 219(1):87-95. PubMed ID: 19479822
[TBL] [Abstract][Full Text] [Related]
15. Surgery of upper GI gastrointestinal stromal tumors: our experience, prognostic analysis.
Kasetsermwiriya W; Nagai E; Nakata K; Nagayoshi Y; Shimizu S; Tanaka M
Hepatogastroenterology; 2015; 62(137):87-92. PubMed ID: 25911874
[TBL] [Abstract][Full Text] [Related]
16. Expression of Fatty Acid-Binding Protein-3 in Gastrointestinal Stromal Tumors and Its Significance for Prognosis.
Chen X; Hu SL; Feng Y; Li P; Mao QS; Xue WJ
J Surg Res; 2021 Apr; 260():462-466. PubMed ID: 33272594
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and prognostic analysis of postoperative recurrence or metastasis of low-risk gastrointestinal stromal tumors.
Cao L; Lin C; Liu Y; Sui C; Li Z; Chen L; Guan W; Tao L; Tao T; Wang M; Wang F
World J Surg Oncol; 2024 Feb; 22(1):65. PubMed ID: 38395931
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological features and prognosis of mesenteric gastrointestinal stromal tumor: evaluation of a pooled case series.
Feng F; Feng B; Liu S; Liu Z; Xu G; Guo M; Lian X; Fan D; Zhang H
Oncotarget; 2017 Jul; 8(28):46514-46522. PubMed ID: 28147326
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of fibrinogen and D-dimer-fibrinogen ratio in resectable gastrointestinal stromal tumors.
Cai HX; Li XQ; Wang SF
World J Gastroenterol; 2018 Nov; 24(44):5046-5056. PubMed ID: 30510379
[TBL] [Abstract][Full Text] [Related]
20. Different sites and prognoses of gastrointestinal stromal tumors of the stomach: report of 187 cases.
Huang H; Liu YX; Zhan ZL; Liang H; Wang P; Ren XB
World J Surg; 2010 Jul; 34(7):1523-33. PubMed ID: 20145924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
